Recall that SGLT2 inhibition attenuates diabetes-induced glomerular hyperfiltration and returns GFR to baseline, lowering the filtered glucose load from 1.52 to 1.3 mol⋅day–1 in moderate diabetes. The gene discussed is SLC5A2; the disease is diabetes mellitus.